The synergism of spatial metabolomics and morphometry improves machine learning-based renal tumour subtype classification

Clin Transl Med. 2022 Feb;12(2):e666. doi: 10.1002/ctm2.666.
No abstract available

Keywords: machine learning; mass spectrometry imaging; metabolomics; morphometry; renal cell carcinoma; tumour of the kidney; tumour subtyping.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Classification / methods*
  • Humans
  • Kidney Neoplasms / classification*
  • Machine Learning / standards*
  • Machine Learning / statistics & numerical data
  • Metabolomics / instrumentation
  • Metabolomics / methods